Pilot study: Absorption and efficacy of multiple hormones delivered in a single cream applied to the mucous membranes of the labia and vagina

被引:14
作者
Glaser, Rebecca L. [1 ]
Zava, David T. [2 ]
Wurtzbacher, Doug [3 ]
机构
[1] Millennium Wellness Ctr, Dayton, OH 45459 USA
[2] ZRT Lab, Beaverton, OR USA
[3] Med Shoppe Pharm, Dayton, OH USA
关键词
gonadal steroid hormones; absorption; vaginal creams; estradiol; estriol; testosterone; progesterone;
D O I
10.1159/000128599
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background/Aims: There is a lack of evidence in the literature supporting vaginal application of a combination hormone-containing cream for local and systemic symptom relief. This pilot study examined the extent of absorption of a single cream containing estriol, estradiol, progesterone, DHEA, and testosterone. Methods: A combination cream was administered to 12 postmenopausal women in two differing doses over two independent time periods. Following 28 days (arm 1) and an additional 14 days (arm 2), measurement of hormones in saliva and blood and measurements of symptom relief, patient tolerability, and health-related quality of life (HRQoL) were obtained. Results: The dosage and time of evaluation for study arm 1 was not ideal for providing documented increases in hormone levels. HRQoL measurements supported measured improvement in this arm. The second arm did document absorption of the various hormones when given vaginally. Conclusion: This study is the first documenting systemic absorption of multiple hormones by both saliva and blood as well as improvement of HRQoL. This therapy was generally well-tolerated with only 2 patients experiencing minor irritation, not necessitating discontinuation. Additional studies in larger numbers of patients will provide better knowledge for clinicians wanting to provide similar therapy at the lowest effective dose. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 61 条
[51]  
Spilker B, 1996, Quality of life and pharmacoeconomics in clinical trials, V2, P1
[52]   Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia - A pilot study [J].
Suh-Burgmann, E ;
Sivret, J ;
Duska, LR ;
Del Carmen, M ;
Seiden, MV .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2003, 55 (01) :25-31
[53]   Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women [J].
Tamimi, Rulla M. ;
Hankinson, Susan E. ;
Chen, Wendy Y. ;
Rosner, Bernard ;
Colditz, Graham A. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (14) :1483-1489
[54]   Current concepts - Assessment of quality-of-life outcomes [J].
Testa, MA ;
Simonson, DC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :835-840
[55]  
TREVOUX R, 1982, Reproduccion, V6, P101
[56]  
VILLANUEVA B, 1981, FERTIL STERIL, V35, P433
[57]   REVIEW OF THE ENDOMETRIAL SAFETY DURING INTRAVAGINAL TREATMENT WITH ESTRIOL [J].
VOOIJS, GP ;
GEURTS, TBP .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 62 (01) :101-106
[58]   A 12-item short-form health survey - Construction of scales and preliminary tests of reliability and validity [J].
Ware, JE ;
Kosinski, M ;
Keller, SD .
MEDICAL CARE, 1996, 34 (03) :220-233
[59]   Low-potency oestrogen and risk of endometrial cancer:: a case-control study [J].
Weiderpass, E ;
Baron, JA ;
Adami, HO ;
Magnusson, C ;
Lindgren, A ;
Bergström, R ;
Correia, N ;
Persson, I .
LANCET, 1999, 353 (9167) :1824-1828
[60]   Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression [J].
Zhou, J ;
Ng, S ;
Adesanya-Famuiya, O ;
Anderson, K ;
Bondy, CA .
FASEB JOURNAL, 2000, 14 (12) :1725-1730